A phase II trial of induction CDDP plus TS-1 with concurrent radiotherapy followed by surgical resection in patients with resectable stage IIIA-N2 non-small cell lung cancer

Phase 2

• Conditions: Stage IIIA-N2 non-small cell lung cancer

• Registration Number: JPRN-UMIN000018138
• Lead Sponsor: Gunma University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-06-30
• Study Completion: 2019-12-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Not provided

Exclusion Criteria

1)History of active infection 2)Severe diarrhea 3)Severe complication (Severe GI disease, bowel obstruction, interstitial pneumonia or pulmonary fibrosis detectable on chest Xp, uncontrollable diabetes mellitus, history of severe heart disease, severe renal disease, severe hepatic disease, Current history of GI ulcer, Current history of myocardial infarction and angina pectoris) 4)Autoimmune disease requiring immunosuppressive agent 5)History of active double cancer 6)History of pregnancy or lactation 7)History of psychiatric disorder 8)Systemic administration of steroid 9)Severe drug allergy 10) Hepatitis Bc antibody or hepatitis Bs antigen positive 11)Administration of flucytosine 12)Investigational new drug or the unapproved drug is administered 13)Any other medical condition that makes the patient unsuitable for inclusion in the study according to the opinion of the investigator

Study & Design

• Study Type: Interventional
• Study Design: Not specified